Advanced search
Publication Cover
Journal of Medical Economics Volume 21, 2018 - Issue 8
Submit an article Journal homepage
573
Views
5
CrossRef citations to date
0
Altmetric
Oncology

First-line systemic treatment adherence, healthcare resource utilization, and costs in patients with gastrointestinal neuroendocrine tumors (GI NETs) in the USA

Michael S. BroderPartnership for Health Analytic Research, LLC, Beverly Hills, CA, USA; Correspondence[email protected]
,
Beilei CaiNovartis Pharmaceuticals, East Hanover, NJ, USA;
,
Eunice ChangPartnership for Health Analytic Research, LLC, Beverly Hills, CA, USA;
,
Tingjian YanPartnership for Health Analytic Research, LLC, Beverly Hills, CA, USA;
&
Al B. Benson IIINorthwestern University, Chicago, IL, USA
Pages 821-826 | Received 08 Dec 2017, Accepted 03 May 2018, Published online: 25 May 2018

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Bernard Tawfik, David Ray, Meghan Moynihan & Nicole Princic. (2021) Costs of treatment change following first-line somatostatin analog monotherapy among patients with neuroendocrine tumors. Journal of Medical Economics 24:1, pages 1337-1345.
Read now
Eva Lesén, Åse Björstad, Ingela Björholt, Tom Marlow, Entela Bollano, Marion Feuilly, Florence Marteau, Staffan Welin, Anna-Karin Elf & Viktor Johanson. (2018) Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study. Scandinavian Journal of Gastroenterology 53:12, pages 1509-1518.
Read now

Articles from other publishers (3)

J. E. Machado-Alba, M. E. Machado-Duque, A. Gaviria-Mendoza, I. N. Arsof-Saab, C. A. Castellanos-Moreno, L. Botero & L. Triana. (2022) Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors. Journal of Endocrinological Investigation 46:1, pages 27-35.
Crossref
Louisa G. Gordon, Thomas M. Elliott, Kate Wakelin, Simone Leyden, John Leyden, Michael Michael, Nick Pavlakis, Jan Mumford, Eva Segelov & David K. Wyld. (2020) The Economic Impact on Australian Patients with Neuroendocrine Tumours. The Patient - Patient-Centered Outcomes Research 13:3, pages 363-373.
Crossref
Rongzhi Wang, Rui Zheng-Pywell, H Alexander Chen, James A Bibb, Herbert Chen & J Bart Rose. (2019) Management of Gastrointestinal Neuroendocrine Tumors. Clinical Medicine Insights: Endocrinology and Diabetes 12, pages 117955141988405.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.